Amended and Restated PDT Product Development, Manufacturing and Distribution Agreement Novartis Pharma AG, and QLT Inc.PDT Product Development, Manufacturing and Distribution Agreement • October 22nd, 2009 • QLT Inc/Bc • Pharmaceutical preparations • New York
This Amended and Restated PDT Product Development, Manufacturing and Distribution Agreement (the “Agreement”) is made effective as of October 16, 2009 (the “Restatement Date”), by and between Novartis Pharma AG, a Swiss corporation having a principal place of business at Lichtstrasse 35, 4056 Basel, Switzerland (“Novartis”) and QLT Inc., a British Columbia company having a principal place of business at 887 Great Northern Way, Suite 101, Vancouver, British Columbia, Canada, V5T 4T5 (“QLT”).
